Home
Boletín de PANAFTOSA - Fiebre Aftosa No. 11
Subject: Boletín de PANAFTOSA - Fiebre Aftosa No. 11
Send date: 2012-10-17 19:16:06
Issue #: 11
Content:
Octubre 2012 / Número: 11

Este Boletín comenzó a editarse en 2006 en formato digital y continuará siendo distribuído mensualmente a la lista de suscriptos en fiebre aftosa y enfermedades vesiculares, para mantener la diseminación selectiva de la información escogida por sus suscriptores, a quienes solicitamos actualizar sus datos en "Change your subscription" al pie. Para quienes estén interesados en recibir el Boletín de PANAFTOSA de los restantes temas, ir a la Web de PANAFTOSA y suscribirse colocando nombre e email (columna de la izquierda, debajo del título "Boletín Electrónico").

 Fiebre Aftosa / Foot-and-Mouth Disease

Accumulation of nucleotide substitutions occurring during experimental transmission of goot-and-mouth disease virus. Juleff N, Valdazo-González B, Wadsworth J, Wright CF, Charleston B, Paton DJ, King DP, Knowles NJ. J Gen Virol. 2012 Oct



Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV. Chai Z, Wang H, Zhou G, Yang D, Wang J, Yu L. J Virol Methods. 2012 Sep



Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against foot-and-mouth disease virus in cattle. Lavoria MA, Di-Giacomo S, Bucafusco D, Franco-Mahecha OL, Pérez-Filgueira DM, Capozzo AV. Vaccine. 2012 Sep



Characterization of epitope-tagged foot-and-mouth disease virus. Seago J, Jackson T, Doel C, Fry E, Stuart D, Harmsen MM, Charleston B, Juleff N. J Gen Virol. 2012 Nov;93(Pt 11):2371-81




CD4+ T-Cell responses to foot-and-mouth disease virus in vaccinated cattle. Carr BV, Lefevre EA, Windsor MA, Inghese C, Gubbins S, Prentice H, Juleff ND, Charleston B. J Gen Virol. 2012 Oct




Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus. Madhanmohan M, Nagendrakumar SB, Manikumar K, Yuvaraj S, Parida S, Srinivasan VA. J Virol Methods. 2012 Aug



Development of foot-and-mouth disease virus (FMDV) serotype O 3 virus-like-particles (VLPs) vaccine and evaluation of its potency. Mohana Subramanian B, Madhanmohan M, Sriraman R, Chandrasekhar Reddy RV, Yuvaraj S, Manikumar K, Rajalakshmi S, Nagendrakumar SB, Rana SK, Srinivasan VA. Antiviral Res. 2012 Oct



Effects of amino acid substitutions in the VP2 B-C loop on antigenicity and pathogenicity of serotype Asia1 foot-and-mouth disease virus. Xue M, Wang H, Li W, Zhou G, Tu Y, Yu L. Virol J. 2012 Sep; 9 (1): 191




Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-a and antiviral agents. Kim SM, Park JH, Lee KN, Kim SK, Ko YJ, Lee HS, Cho IS. Antiviral Res. 2012  Nov; 96 (2): 213–220




FMDV induces autophagosomes during cell entry via a class III PI3K-independent pathway. Berryman S, Brooks E, Burman A, Hawes P, Roberts R, Netherton C, Monaghan P, Whelband M, Cottam E, Elazar Z, Jackson T, Wileman T. J Virol. 2012 Sep



Generation of monoclonal antibodies against non-structural protein 3AB of foot-and-mouth disease virus. Lin T, Shao J, Chang H, Gao S, Cong G, Du J. Virol Sin. 2012 Oct;27(5):316-9




Identification of peptides from foot-and-mouth disease virus structural proteins bound by class I swine leukocyte antigen (SLA) alleles, SLA-1*0401 and SLA-2*0401. Pedersen LE, Harndahl M, Nielsen M, Patch JR, Jungersen G, Buus S, Golde WT. Anim Genet. 2012 Sep



Phylogeography of foot-and-mouth disease virus serotype O in Ecuador. Carvalho LMF, Santos LBL, Faria NR, Silveira WC. Infect Genet Evol. 2012 Sep




Plasma membrane Phosphatidylinositol 4,5 Bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus. Vázquez-Calvo A, Sobrino F, Martín-Acebes MA.
PLoS One. 2012;7(9):e45172



A Safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. Uddowla S, Hollister J, Pacheco JM, Rodriguez LL, Rieder E. J Virol. 2012 Nov;86(21):11675-85



WRLFMD Quarterly Report April-June 2012





Destacados

FAO/OIE Global Conference on Foot and Mouth Disease Control. Bangkok, Thailand 27-29 June 2012. Recommendations




Higher education: beyond the farm. Maxmen A. Nature 2012; 490: 131-132





NEW AND REVISED OIE STANDARDS ADOPTED AT 80th GENERAL SESSION



NORMAS NUEVAS Y REVISADAS DE LA OIE ADOPTADAS DURANTE LA 80a SESIÓN GENERAL

Roadmap for Veterinary Medical Education in the 21st Century: Responsive, Collaborative, Flexible. NAVMEC Report and Recomendations

Sobre el Boletín: Favoreciendo la diseminación equitativa de información relevante en el área de fiebre aftosa y enfermedades vesiculares, el Boletín surge como una fuente de información estratégica para atender las necesidades técnico-científicas de los profesionales del área así como a quien tenga interés. Algunas informaciones están disponibles solamente en su idioma original.

Preparado y editado por:
Astrid Pimentel
Alberto Mendía
Gestión del Conocimiento y Comunicaciones - PANAFTOSA


Enviar solicitudes, comentarios y sugerencias a:
apimente@panaftosa.ops-oms.org

[SUBSCRIPTIONS]

Area de Vigilancia Sanitaria Prevención y Control de las Enfermedades
Salud Pública Veterinaria / PANAFTOSA
Organización Panamericana de la Salud
Av. Governador Leonel de Moura Brizola, 7778 - 25045-002 - São Bento - Duque de Caxias/RJ - Brasil
Tel: (55 21) 3661-9045 - Fax: (55 21) 3661-9027


Regional Office of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: (202) 974-3000 Fax: 974-3663

© Pan American Health Organization. All rights reserved.